← Leaderboards
Frank M Longo
Northern California Institute Res &Educ
$8,079,856
Attributed
$8,298,435
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.5M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$48,588,165 · 10
By mechanism
U54$40,289,730 · 2
U01$4,671,407 · 1
R21$2,168,770 · 5
R01$1,171,200 · 1
R25$287,058 · 1
Top collaborators
- Gregory W Carter5 shared
- Aled M Edwards5 shared
- Haian Fu5 shared
- Allan I Levey5 shared
- Stephen Vernon Frye3 shared
- Opher Gileadi3 shared
- Lara M Mangravite3 shared
- Alison Donnelly Axtman2 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposProgramsResearch PersonnelS DiseaseBaseAffectNeurodegenerative DisordersPharmaceutical PreparationsInvestigationLaboratoriesMouse ModelBrainScientistNeuronsLigandsSmall MoleculeSignal TransductionPlayFundingPreventRecordsMemoryValidationNgfr Protein
Grant awards (36)
Development of Human Microphysiological Systems for Testing of AD/ADRD Interventional Strategies across Genetically Diverse Populations$3,708,714
U54 · FY2025 · AG
Open Drug Discovery Center for Alzheimer's Disease$7,132,571
U54 · FY2023 · AG
Open Drug Discovery Center for Alzheimer's Disease$7,217,536
U54 · FY2022 · AG
Open Drug Discovery Center for Alzheimer's Disease$7,311,958
U54 · FY2021 · AG
Open Drug Discovery Center for Alzheimer's Disease$7,420,073
U54 · FY2020 · AG
Open Drug Discovery Center for Alzheimer's Disease$7,498,878
U54 · FY2019 · AG
Small molecule neurotrophin receptor ligands to treat Alzheimer's disease$196,250
R21 · FY2018 · AG · contact PI
Small molecule neurotrophin receptor ligands to treat Alzheimer's disease$237,671
R21 · FY2017 · AG · contact PI
New PET imaging agent for monitoring treatment response in Alzheimer's disease$198,927
R21 · FY2016 · AG
New PET imaging agent for monitoring treatment response in Alzheimer's disease$238,232
R21 · FY2015 · AG
Small Molecule p75 Neurotrophin Receptor Ligand to Treat Huntington's Disease$194,703
R21 · FY2014 · NS · contact PI
Stanford Neurology Resident Research Track$89,639
R25 · FY2014 · NS · contact PI
Stanford Neurology Resident Research Track$1,080
R25 · FY2014 · NS · contact PI
Stanford Neurology Resident Research Track$1
R25 · FY2014 · NS · contact PI
Small Molecule p75 Neurotrophin Receptor Ligand to Treat Huntington's Disease$236,006
R21 · FY2013 · NS · contact PI
P75NTR Small Molecule Ligands for Down Syndrome Therapy$189,381
R21 · FY2013 · NS · contact PI
Stanford Neurology Resident Research Track$51,702
R25 · FY2013 · NS · contact PI
Stanford Neurology Resident Research Track$1
R25 · FY2013 · NS · contact PI
P75NTR Small Molecule Ligands for Down Syndrome Therapy$235,500
R21 · FY2012 · NS · contact PI
P75 Small Molecule Ligands for Alzheimer's Therapy$100,000
U01 · FY2012 · AG · contact PI
Stanford Neurology Resident Research Track$1
R25 · FY2012 · NS · contact PI
P75 Small Molecule Ligands for Alzheimer's Therapy$829,613
U01 · FY2011 · AG · contact PI
Small Molecule Neurotrophin Mimetics to Treat Huntington's Disease$200,630
R21 · FY2011 · NS · contact PI
Stanford Neurology Resident Research Track$75,600
R25 · FY2011 · NS · contact PI
Stanford Neurology Resident Research Track$1
R25 · FY2011 · NS · contact PI
P75 Small Molecule Ligands for Alzheimer's Therapy$850,142
U01 · FY2010 · AG · contact PI
Small Molecule Neurotrophin Mimetics to Treat Huntington's Disease$241,470
R21 · FY2010 · NS · contact PI
Stanford Neurology Resident Research Track$69,033
R25 · FY2010 · NS · contact PI
P75 Small Molecule Ligands for Alzheimer's Therapy$861,856
U01 · FY2009 · AG · contact PI
P75 Small Molecule Ligands for Alzheimer's Therapy$246,792
U01 · FY2009 · AG · contact PI
P75 Small Molecule Ligands for Alzheimer's Therapy$847,101
U01 · FY2008 · AG · contact PI
P75 Small Molecule Ligands for Alzheimer's Therapy$935,903
U01 · FY2007 · AG · contact PI
NOVEL LAR ISOFORMS: A NEW CLASS OF NEUROTROPHIC AGENTS$291,000
R01 · FY2003 · AG
NOVEL LAR ISOFORMS: A NEW CLASS OF NEUROTROPHIC AGENTS$291,000
R01 · FY2002 · AG
NOVEL LAR ISOFORMS--A NEW CLASS OF NEUROTROPHIC AGENTS$291,000
R01 · FY2001 · AG
NOVEL LAR ISOFORMS--A NEW CLASS OF NEUROTROPHIC AGENTS$298,200
R01 · FY2000 · AG